TRIM13 antibody (Middle Region)
Quick Overview for TRIM13 antibody (Middle Region) (ABIN1109332)
Target
See all TRIM13 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Middle Region
-
Sequence
- DTLETSKRKS LQLLTKDSDK VKEFFEKLQH TLDQKKNEIL SDFETMKLAV
-
Cross-Reactivity (Details)
- Species reactivity (expected):Rat, Mouse, BovineSpecies reactivity (tested):Human
-
Purification
- Purified using peptide immunoaffinity column
-
Immunogen
- The immunogen for anti-TRIIM13 antibody: synthetic peptide directed towards the middle region of human TRIM13
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Reconstitution
- Add 50 μL of distilled water to a final concentration of 1 mg/mL.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store lyophilized at 2-8 °C or at -20 °C long term. After reconstitution store the antibody undiluted at 2-8 °C for up to one month or in aliquots at -20 °C long term.
-
-
- TRIM13 (Tripartite Motif Containing 13 (TRIM13))
-
Alternative Name
- TRIM13 / RNF77
-
Background
- TRIM13 is an E3 ubiquitin ligase involved in the retrotranslocation and turnover of membrane and secretory proteins from the ER through a set of processes named ER-associated degradation (ERAD). This process acts on misfolded proteins as well as in the regulated degradation of correctly folded proteins. TRIM13 enhances ionizing radiation-induced p53/TP53 stability and apoptosis via ubiquitinating MDM2 and AKT1 and decreasing AKT1 kinase activity through MDM2 and AKT1 proteasomal degradation, regulates ER stress-induced autophagy, and may act as a tumor suppressor.Synonyms: B-cell chronic lymphocytic leukemia tumor suppressor Leu5, LEU5, Leukemia-associated protein 5, Putative tumor suppressor RFP2, RFP2, RING finger protein 77, Tripartite motif-containing protein 13
-
Gene ID
- 10206
-
NCBI Accession
- NP_005789
Target
-